adamantane has been researched along with Respiratory Tract Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borja-Hart, NL; Whalen, KL | 1 |
| Gergert, VIa; Khomenko, IS; Kossii, NV | 1 |
1 review(s) available for adamantane and Respiratory Tract Infections
| Article | Year |
|---|---|
Saxagliptin: a new dipeptidyl peptidase 4 inhibitor for type 2 diabetes.
Topics: Adamantane; Animals; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Headache; Humans; Respiratory Tract Infections | 2010 |
1 other study(ies) available for adamantane and Respiratory Tract Infections
| Article | Year |
|---|---|
[Treatment of immunodeficient conditions caused by viral infection with the Soviet immunomodulator kemantan in patients with pulmonary tuberculosis].
Topics: Adamantane; Adjuvants, Immunologic; Adult; Humans; Immunologic Deficiency Syndromes; Male; Middle Aged; Respiratory Tract Infections; Tuberculosis, Pulmonary; Virus Diseases | 1991 |